Cargando…
Assessment of the high risk and unmet need in patients with CAD and type 2 diabetes (ATHENA): US healthcare resource utilization, cost and burden of illness in the Diabetes Collaborative Registry
BACKGROUND: THEMIS (NCT01991795) showed that in patients with type 2 diabetes (T2D) and stable coronary artery disease (CAD) but with no prior myocardial infarction (MI) or stroke, ticagrelor plus acetylsalicylic acid (ASA) decreased the incidence of ischaemic cardiovascular events compared with pla...
Autores principales: | Wittbrodt, Eric, Bhalla, Narinder, Andersson Sundell, Karolina, Gao, Qi, Dong, Liyan, Cavender, Matthew A., Hunt, Phillip, Wong, Nathan D., Mellström, Carl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375123/ https://www.ncbi.nlm.nih.gov/pubmed/32704557 http://dx.doi.org/10.1002/edm2.133 |
Ejemplares similares
-
Recent Results of the Athena Collaboration
por: Rotondi, Alberto, et al.
Publicado: (2006) -
Antihydrogen Production and Precision Experiments The ATHENA Collaboration
por: Van der werf, D P, et al.
Publicado: (2002) -
Athena’s Reply
por: V, Raveenthiran
Publicado: (2015) -
Athena's Pages
por: Raveenthiran, V
Publicado: (2012) -
Eligibility of patients with type 2 diabetes for sodium‐glucose co‐transporter‐2 inhibitor cardiovascular outcomes trials: An assessment using the Diabetes Collaborative Registry
por: Wittbrodt, Eric, et al.
Publicado: (2019)